PICAMILON ® [Nicotinoyl-GABA]

Dosage and administration 

Typical daily dose: 30 - 50 mg once or twice a day.

Side effects 

Side effects occur in approximately 12% of patients and are characterised by moderate headaches, insomnia, fatigue and allergic reactions.

Overdose 

Сonsuming too much might result in an increase in potential side effects.

Country of Manufacture: Russia

You can read the full instruction here

Unlike its younger brother Phenibut, Picamilon was ironically synthesised in the USSR for common people and not for cosmonauts.

This compound is based on a synthetic combination of GABA and niacin, with the former being responsible for reducing neuronal excitability and the latter acting as a strong vasodilator. 

Its effects are similar to those of Phenibut as both drugs reduce anxiety and improve mood. However, unlike Phenibut, Picamilon has a much stronger impact on the energy metabolism in the brain because it stimulates consumption of oxygen and glucose by the neuronal tissue.  

Similar to Phenibut Picamilon should be taken for a period of maximum 3 weeks and has the capacity to cause withdrawal syndrome if abused.

Picamilon can be used to treat the following symptoms and conditions:

  • Cerebrovascular diseases
  • Migraine
  • Asthenic disorders (lack of energy)
  • Depressions
  • Alcohol withdrawal syndrome

One pack of Picamilon ® contains 30 pills, each 30 or 50 Mg of active ingredient, which is sufficient for approximately 15 - 30 days of administration.

Country of Manufacture: Russia

Availability: in stock

The product is available in different sizes. You can save by choosing a larger size.

  1. Voznesenskii et al (1989) Comparative study of the effect of picamilone and piracetam on learning in rats in a radial maze https://www.unboundmedicine.com/medline/citation/2806520/
  2. I Sapegin, A Beketov (1993) The effect of pikamilon and fenibut on the blood supply of the brain at rest and under gravitational exposures https://www.ncbi.nlm.nih.gov/pubmed/8324468
  3. Shyman’kyi et al (2002) Oxidative stress correction by nicotinamide and nicotynol-GABA in diabetic neuropathy https://www.ncbi.nlm.nih.gov/pubmed/12916162
  4. Kuchmerovs’ka et al (2003) State of GABA-benzodiazepine receptor complex in diabetic neuropathy: effect of nicotinamide and nicotinoyl-GABA https://www.ncbi.nlm.nih.gov/pubmed/14577176
  5. Silkina et al (2005) Gabaergic mechanism of cerebrovascular and neuroprotective effects of afobazole and picamilon https://www.ncbi.nlm.nih.gov/pubmed/15786959
  6. Likhodeev et al (2009) Effects of aminalon, fenibut, and picamilon on the typological parameters of cerebral hemodynamics in swimmers with dysadaptation syndrome https://www.ncbi.nlm.nih.gov/pubmed/19803364
  7. Avula et al (2016) Identification and quantification of vinpocetine and picamilon in dietary supplements sold in the United States https://www.ncbi.nlm.nih.gov/pubmed/26426301


Type: Nootropics




CUSTOMERS WHO BOUGHT THIS PRODUCT ALSO BOUGHT